AU2003275416A1 - Compatible host/vector systems for expression of dna - Google Patents

Compatible host/vector systems for expression of dna

Info

Publication number
AU2003275416A1
AU2003275416A1 AU2003275416A AU2003275416A AU2003275416A1 AU 2003275416 A1 AU2003275416 A1 AU 2003275416A1 AU 2003275416 A AU2003275416 A AU 2003275416A AU 2003275416 A AU2003275416 A AU 2003275416A AU 2003275416 A1 AU2003275416 A1 AU 2003275416A1
Authority
AU
Australia
Prior art keywords
dna
expression
vector systems
compatible host
compatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003275416A
Other versions
AU2003275416A8 (en
Inventor
Veronique Dartois
James A. Hoch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMBIOSIS PHARMACEUTICALS
Original Assignee
EMBIOSIS PHARMACEUTICALS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EMBIOSIS PHARMACEUTICALS filed Critical EMBIOSIS PHARMACEUTICALS
Publication of AU2003275416A8 publication Critical patent/AU2003275416A8/en
Publication of AU2003275416A1 publication Critical patent/AU2003275416A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003275416A 2002-10-04 2003-10-03 Compatible host/vector systems for expression of dna Abandoned AU2003275416A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42112002P 2002-10-04 2002-10-04
US60/421,120 2002-10-04
PCT/US2003/031383 WO2004033633A2 (en) 2002-10-04 2003-10-03 Compatible host/vector systems for expression of dna

Publications (2)

Publication Number Publication Date
AU2003275416A8 AU2003275416A8 (en) 2004-05-04
AU2003275416A1 true AU2003275416A1 (en) 2004-05-04

Family

ID=32094169

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275416A Abandoned AU2003275416A1 (en) 2002-10-04 2003-10-03 Compatible host/vector systems for expression of dna

Country Status (2)

Country Link
AU (1) AU2003275416A1 (en)
WO (1) WO2004033633A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100738002B1 (en) * 2005-02-16 2007-07-13 주식회사 엘지화학 Rhodococcus-E. coli shuttle vector
GB0611484D0 (en) * 2006-06-09 2006-07-19 Sinvent As Plasmid RK2-based broad-host-range cloning vector useful for transfer of metagenomic libraries to a variety of bacterial species
WO2009106093A1 (en) * 2008-02-27 2009-09-03 Wageningen Universiteit Methods for identifying one or more bioactive genes
PT2284273E (en) * 2009-08-10 2013-01-14 Lonza Ag Vector comprising mannose promoter and mannose promoter
EP2292769A1 (en) * 2009-08-10 2011-03-09 Lonza AG Fermentation process
CN101899469B (en) * 2010-05-14 2012-10-10 上海艾魁英生物科技有限公司 Shuttle plasmid and method for efficiently expressing cecropin and lysozyme genes
CN101948865B (en) * 2010-08-17 2012-11-14 复旦大学 Dual-promoter inducible secretable shuttle plasmid and construction method thereof
GB201307528D0 (en) 2013-04-26 2013-06-12 Univ Leuven Kath Bacterial artificial chromosomes
GB201514510D0 (en) 2015-08-14 2015-09-30 Nemesis Bioscience Ltd Delivery vehicle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155594A3 (en) * 1984-03-06 1987-10-07 Massachusetts Institute Of Technology Cloned plasmids of corynebacterium
CA1238591A (en) * 1984-09-27 1988-06-28 Ramachandra N. Rao Recombinant dna cosmid shuttle vectors
US4920054A (en) * 1986-07-25 1990-04-24 Allelix, Inc. Shuttle vectors from rhodococcus equi

Also Published As

Publication number Publication date
AU2003275416A8 (en) 2004-05-04
WO2004033633A2 (en) 2004-04-22
WO2004033633A3 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
AU2003245441A1 (en) Cancer-linked gene as target for chemotherapy
AU2003229294A1 (en) Cancer-linked gene as target for chemotherapy
AU2003239969A1 (en) Cancer-linked gene as target for chemotherapy
AU2003249691A1 (en) Cancer-linked gene as target for chemotherapy
AU2003299112A1 (en) Laas navigation system
AU2003259291A1 (en) Virtual reality immersion system
AU2003275416A1 (en) Compatible host/vector systems for expression of dna
AU2003225744A1 (en) Financial system for isolated economic environment
AU2002950473A0 (en) Expression system
AU2003272498A1 (en) Fragmentation of dna
AU2002330401A1 (en) Gene overexpression system
AU2003273035A1 (en) Gene vaccine
AU2001266740A1 (en) Promoters for regulated gene expression
AU2003271883A1 (en) Vector system
AU2003294705A1 (en) NtSM GENE
AU2003253677A1 (en) Cancer-linked gene as target for chemotherapy
AU2003238897A1 (en) Cancer-linked gene as target for chemotherapy
AU2003213743A1 (en) Cancer-linked gene as target for chemotherapy
AU2003277902A1 (en) Acc gene
AU2002317373A1 (en) Control of gene expression
AU2003229293A1 (en) Cancer-linked gene as target for chemotherapy
AU2003247564A1 (en) Cancer-linked gene as target for chemotherapy
AU2003237414A1 (en) Cancer-linked gene as target for chemotherapy
AU2003230611A1 (en) Cancer-linked gene as target for chemotherapy
AU2003218014A1 (en) Cancer-linked gene as target for chemotherapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase